Comparison of dimethyl fumarate and interferon outcomes in an MS cohort.
Sattarnezhad N, Healy BC, Baharnoori M, Diaz-Cruz C, Stankiewicz J, Weiner HL, Chitnis T.
BMC Neurol. 2022 Jul 11. 22(1):252. PMID: 35820822
Secondary Faculty
Brian Curran Healy
Other Positions
Associate Professor of Neurology
Neurology-Brigham and Women's Hospital
Harvard Medical School
Links
Bibliography
Estimating the association between physical activity and health-related quality of life in individuals with multiple sclerosis.
Healy BC, Casady EC, Chitnis T, Weiner HL, Glanz BI.
Mult Scler Relat Disord. 2022 Sep. 65:104006. PMID: 35816952
Peripartum disease activity in moderately and severely disabled women with multiple sclerosis.
Ostrem BL, Anderson A, Conway S, Healy BC, Oh J, Jacobs D, Dobson R, Graham EL, Sadovnick AD, Zimmerman V, Liu Y, Bove R, Houtchens M.
Mult Scler J Exp Transl Clin. 2022 Apr-Jun. 8(2):20552173221104918. PMID: 35734229
COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders.
Conway SE, Healy BC, Zurawski J, Severson C, Kaplan T, Stazzone L, Galetta K, Chitnis T, Houtchens MK.
Mult Scler Relat Disord. 2022 Jul. 63:103946. PMID: 35709663
microRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balance.
Fujiwara M, Raheja R, Garo LP, Ajay AK, Kadowaki-Saga R, Karandikar SH, Gabriely G, Krishnan R, Beynon V, Paul A, Patel A, Saxena S, Hu D, Healy BC, Chitnis T, Gandhi R, Weiner HL, Murugaiyan G.
J Clin Invest. 2022 05 16. 132(10). PMID: 35298438
Early Predictors of Clinical and MRI Outcomes Using Least Absolute Shrinkage and Selection Operator (LASSO) in Multiple Sclerosis.
Bose G, Healy BC, Lokhande HA, Sotiropoulos MG, Polgar-Turcsanyi M, Anderson M, Glanz BI, Guttman CRG, Bakshi R, Weiner HL, Chitnis T.
Ann Neurol. 2022 07. 92(1):87-96. PMID: 35429009
Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination.
North CM, Barczak A, Goldstein RH, Healy BC, Finkelstein DM, Ding DD, Kim A, Boucau J, Shaw B, Gilbert RF, Vyas T, Reynolds Z, Siddle KJ, MacInnis BL, Regan J, Flynn JP, Choudhary MC, Vyas JM, Laskowski K, Dighe AS, Lemieux JE, Li JZ, Baden LR, Siedner MJ, Woolley AE, Sacks CA.
Clin Infect Dis. 2022 04 09. 74(7):1275-1278. PMID: 34363462
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis.
Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, Elledge SJ, Niebuhr DW, Scher AI, Munger KL, Ascherio A.
Science. 2022 01 21. 375(6578):296-301. PMID: 35025605
Serum NfL levels in the first five years predict 10-year thalamic fraction in patients with MS.
Lokhande H, Rosso M, Tauhid S, Chu R, Healy BC, Saxena S, Barro C, Paul A, Polgar-Turcsanyi M, Anderson M, Glanz BI, Kropshofer H, Granziera C, Leppert D, Kappos L, Kuhle J, Weiner HL, Bakshi R, Chitnis T.
Mult Scler J Exp Transl Clin. 2022 Jan-Mar. 8(1):20552173211069348. PMID: 35035990
Demand with low supply: A pipeline for personalized integrative medicine in multiple sclerosis.
Manglani HR, Healy BC, Vranceanu AM.
Mult Scler Relat Disord. 2022 Feb. 58:103493. PMID: 35030367